You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • AB0619 Autologous Non-Myeloablative Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: The Benefit of Quantitative Chest-CT Analysis for Response of Lung Involvement and Comparison with Results of Pulmonary Function Tests and Clinical Tests

Citation Tools

Article menu
Download PDFPDF
Abstracts Accepted for Publication
Scleroderma, myositis and related syndromes
AB0619 Autologous Non-Myeloablative Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: The Benefit of Quantitative Chest-CT Analysis for Response of Lung Involvement and Comparison with Results of Pulmonary Function Tests and Clinical Tests

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Marius M, Xenitidis T, Koetter I, et al
AB0619 Autologous Non-Myeloablative Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: The Benefit of Quantitative Chest-CT Analysis for Response of Lung Involvement and Comparison with Results of Pulmonary Function Tests and Clinical Tests
Annals of the Rheumatic Diseases 2016;75:1115-1116.